Nutritional Status and Body Composition of Adult Patients With Crohn's Disease

A Multi-center, Cross-sectional Observational Study on Nutritional Status and Body Composition of Adult Patients With Crohn's Disease

Patients with Crohn's disease generally have nutritional risks and malnutrition. The investigators will conduct a multicenter cross-sectional study to discover nutritional status and body composition of Chinese adult patients with CD.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Several studies have found that the body composition of CD patients is related to disease and therapies. Due to lack of a prospective multicenter cross-sectional observational study on the nutritional status and body composition of adult patients with CD in China. Evaluating the nutritional status and body composition of these patients can help formulate individualized nutritional support strategies for adult CD patients.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310009
        • Recruiting
        • 2nd Affiliated Hospital, School of Medicine, Zhejiang University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Chinese adult patients with Crohn's Disease

Description

Inclusion Criteria:

  • Age ≥ 18 years old;
  • diagnosis of CD;
  • Admission time <48 hours;
  • Subject has voluntarily signed and dated an informed consent form.

Exclusion Criteria:

  • Emergency surgery for intestinal fistula or abdominal abscess;
  • Unstable vital signs or unstable hemodynamics;
  • Pregnant or lactating women;
  • Admission to hospital due to other critical illnesses (such as tumor, HIV, severe infections requiring ventilator or CRRT treatment);
  • Dying patients whose life expectancy does not exceed 24 hours;
  • Severe liver insufficiency (liver function score 11-15 or total bilirubin> 3mg/dL or tissue biopsy diagnosed as liver cirrhosis, hepatic encephalopathy, portal hypertension with history of gastrointestinal hemorrhage, etc.);
  • Severe renal insufficiency (creatinine value is 2 times higher than the upper limit of normal);
  • Severe metabolic diseases (such as metabolic syndrome, hyperthyroidism, etc.);
  • Patients whose burn area exceeds 20% of the body surface area;
  • Immunodeficiency, autoimmune disease, or receiving immunosuppressive treatment for diseases other than CD (such as organ transplantation, etc.);
  • Those who are not suitable for body composition analysis
  • Patients who have been selected for other clinical studies or have been selected for this study;
  • Subjects are unwilling to participate in this study or refuse to sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
adult patients with Crohn's disease
multi-center cross-sectional study
cross-sectional study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appendicular skeletal mass index
Time Frame: Within 48 hours of admission to hospital
Bioelectrical impedance analysis
Within 48 hours of admission to hospital

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition
Time Frame: Within 48 hours of admission to hospital
Especially body fat mass by bioelectrical impedance analysis
Within 48 hours of admission to hospital
Nutritional risk screening
Time Frame: Within 48 hours of admission to hospital
Detect the presence of undernutrition and the risk of developing undernutrition by Risk Screening 2002 (NRS-2002), when score≥3, the patient is nutritionally at-risk
Within 48 hours of admission to hospital
Nutritional assessment
Time Frame: Within 48 hours of admission to hospital
Detect malnourished individuals by the Subjective Global Assessment (SGA) , where A is well nourished and C is severely malnourished
Within 48 hours of admission to hospital
Grip strength
Time Frame: Within 48 hours of admission to hospital
Hand grip strength test
Within 48 hours of admission to hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

April 11, 2021

First Submitted That Met QC Criteria

May 31, 2021

First Posted (Actual)

June 7, 2021

Study Record Updates

Last Update Posted (Actual)

July 15, 2021

Last Update Submitted That Met QC Criteria

July 14, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crohn Disease

Clinical Trials on cross-sectional study

Subscribe